RhumbLine Advisers’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-17,394	Closed	-$29K	–	3349
2022 Q1	$29K	Buy	17,394 +1,201	+7%	+$2K	﹤0.01%	2997
2021 Q4	$39K	Buy	16,193 +5,818	+56%	+$14K	﹤0.01%	2989
2021 Q3	$57K	Sell	10,375 -467	-4%	-$2.57K	﹤0.01%	3023
2021 Q2	$81K	Buy	+10,842	New	+$81K	﹤0.01%	2972